# Nu Image Medical reviews (2026): GLP-1 telehealth sellers | This GLP

Four products sit on one page, and the figure that draws the eye is a year bought at once.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/nu-image-medical
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Four cards, four units

# Nu Image Medical review

Four products sit on one page, and the figure that draws the eye is a year bought at once.

## The verdict

Nu Image Medical prices four weight-loss products on a single page and labels each as an as-low-as figure. The $99 semaglutide injection carries the words twelve-month supply on its own card, and the tirzepatide injection is $289 rather than the $269 that belongs to the rapid-dissolve tablet beside it.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection · Oral

Injection

From $289/mo

Oral

From $269/mo

Dose published

No

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

Nu Image Medical is a telehealth practice that has been selling online since 2008, offering compounded semaglutide and tirzepatide as weekly injections and as daily rapid-dissolve tablets. A structured nutrition program is sold alongside them. Testosterone, peptides and several other lines share the same catalog.

1.  ## Who writes the prescription, and what do they see?
    
    A licensed provider determines eligibility before anything is dispensed, which the page states in the same paragraph as its prices rather than in a footer. Beyond that the clinical model is thinly described: no prescriber is named, and nothing sets out what is reviewed, or when a patient next speaks to anyone. Ongoing support is listed as a feature without being defined.
    
    The four products are bought as programs of differing length rather than as a uniform monthly plan, which is why their headline figures are not comparable with one another. The injection sold at the lowest rate is explicitly a year's supply. Shipping is described as discreet, and the practice reports a 4.4 rating across roughly a thousand public reviews.
    
2.  ## What happens when the dose goes up?
    
    Nothing on the weight-loss page ties a figure to a milligram, and no dose ladder is published for either molecule or either format. A buyer therefore cannot tell whether an escalation changes the charge, shortens the supply, or neither. That silence matters more here than elsewhere, because the $99 card commits a patient for twelve months before the first step is taken.
    
3.  ## What the price includes
    
    The page's own summary sentence is the clearest thing on it: weekly injections from $99 and $289 a month. The $99 is the twelve-month semaglutide commitment and no month-to-month figure for that injection is published anywhere, while $269 and $314 price the semaglutide and tirzepatide tablets rather than a needle. Reading the tablet figure onto the injection understates the injection by $20 a month.
    
4.  ## What it claims, and what it cites
    
    Every line on the page is marked as compounded and prescription-only, prepared by a pharmacy rather than manufactured. The hero states that compounded medications are not FDA-approved, which puts the disclosure beside the prices instead of underneath them. No compounding pharmacy is named.
    

## Where it holds up, and where it does not

-   Strength: Both an injection and a dissolving tablet are offered
-   Strength: The compounded disclosure sits next to the prices
-   Strength: A long trading history is stated and dated
-   Strength: The summary line names the injection rates directly
-   Limitation: The lowest figure is a twelve-month supply
-   Limitation: No month-to-month rate is published for the injection
-   Limitation: Tablet and injection prices sit side by side without a unit
-   Limitation: No milligram dose appears anywhere

## What the evidence says about this kind of treatment

The assessment above is about Nu Image Medical. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A buyer choosing between a weekly injection and a daily tablet from one practice.

Wrong for

A buyer who wants to pay month to month for the injection.

## The evidence behind what Nu Image Medical prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Nu Image Medical compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Care Clinics | Readers who will do the division themselves and want the week counts published to do it with |  |
| MyStart Health | Buyers who titrate quickly and want the rate frozen before the dose climbs |  |
| Rx.com | Buyers ready to pay six months at once for the figure in the headline |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Rewinding RX](https://thisglp.com/reviews/rewinding-rx) [Rex MD](https://thisglp.com/reviews/rex-md) [Rivas Medical Weight Loss](https://thisglp.com/reviews/rivas-medical) [Rivo Health](https://thisglp.com/reviews/rivo-health) [Rixa Health](https://thisglp.com/reviews/rixa-health) [RNK Health](https://thisglp.com/reviews/myrnk)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Is $99 a monthly rate?

No. That card states a twelve-month supply, and Nu Image publishes no month-to-month figure for the semaglutide injection.

What does the tirzepatide injection cost?

$289 a month. The $269 and $314 figures belong to the rapid-dissolve tablets rather than to an injection.

Are these FDA-approved medications?

No. Every GLP-1 line here is compounded, and the page says compounded medications are not FDA-approved.

Is Nu Image Medical expensive compared with other GLP-1 telehealth sellers?

Nu Image Medical publishes a starting figure of $269/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Nu Image Medical above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
